TIM-3 blocking antibodies result in enhanced anti-tumor T cell responses and control of tumor growth in murine solid cancer models, especially when combined with PD-1 and CTLA-4-blocking antibodies [12,58,59]. The gene discussed is PDCD1; the disease is neoplasm.